297 related articles for article (PubMed ID: 17108865)
1. Treatment of irritable bowel syndrome. A case control experience.
Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
4. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
[TBL] [Abstract][Full Text] [Related]
5. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome.
Tsuchiya J; Barreto R; Okura R; Kawakita S; Fesce E; Marotta F
Chin J Dig Dis; 2004; 5(4):169-74. PubMed ID: 15612887
[TBL] [Abstract][Full Text] [Related]
6. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
7. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
10. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
Leventer SM; Raudibaugh K; Frissora CL; Kassem N; Keogh JC; Phillips J; Mangel AW
Aliment Pharmacol Ther; 2008 Jan; 27(2):197-206. PubMed ID: 17973974
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
Plassmann D; Schulte-Witte H
Med Klin (Munich); 2007 Nov; 102(11):888-92. PubMed ID: 17992479
[TBL] [Abstract][Full Text] [Related]
13. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for irritable bowel syndrome in Turkish population: role of food allergy.
Uz E; Türkay C; Aytac S; Bavbek N
J Clin Gastroenterol; 2007 Apr; 41(4):380-3. PubMed ID: 17413606
[TBL] [Abstract][Full Text] [Related]
15. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
[TBL] [Abstract][Full Text] [Related]
16. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome.
Zar S; Mincher L; Benson MJ; Kumar D
Scand J Gastroenterol; 2005 Jul; 40(7):800-7. PubMed ID: 16109655
[TBL] [Abstract][Full Text] [Related]
17. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
[TBL] [Abstract][Full Text] [Related]
18. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
19. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM
Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
[TBL] [Abstract][Full Text] [Related]
20. [Clinical observation on acupuncture combined with microorganism pharmaceutical preparations for treatment of irritable bowel syndrome of constipation type].
Long ZR; Yu CH; Yang Y; Wang HN; Chi XX
Zhongguo Zhen Jiu; 2006 Jun; 26(6):403-5. PubMed ID: 16813181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]